Teva Wins FDA Approval for Monthly Schizophrenia Injectable WELTRUZA
Nasdaq
MarketBeat Week in Review – 02/03 - 02/07 Teva Pharmaceutical Industries (NYSE:TEVA) said the U.S. Food and Drug Administration has approved WELTRUZA, a once-monthly subcutaneous long-acting…









